![Lawrence C. Best](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lawrence C. Best
Gründer bei
OXO Capital LLC
Profil
Lawrence C.
Best is the founder and currently holds the position of Chairman at OXO Capital LLC, which was founded in 2007.
He is also currently the Chairman at NeoSync, Inc. and the Director at 4Tech Cardio Ireland Ltd. Mr. Best previously held the position of Executive Chairman at Valtech Cardio Ltd. and Cardiovalve Ltd. He also served as a Director at Biogen MA, Inc. and Biogen, Inc. From 2003 to 2014, Mr. Best was an Independent Director at Haemonetics Corp.
and from 2009 to 2020, he held the same position at Myriad Genetics, Inc. He was a Director at Archemix Corp.
and Biogen Idec New Ventures, Inc. Mr. Best was also a Founding Director-Presidents Council at The General Hospital Corp.
He started his career as a Senior Partner at Ernst & Young LLP from 1981 to 1992.
Mr. Best obtained his undergraduate degree from Kent State University (Ohio).
Aktive Positionen von Lawrence C. Best
| Unternehmen | Position | Beginn |
|---|---|---|
OXO Capital LLC
 OXO Capital LLC Financial ConglomeratesFinance Operates as an investment company | Gründer | 01.01.2007 |
4Tech Cardio Ireland Ltd.
 4Tech Cardio Ireland Ltd. Medical SpecialtiesHealth Technology Develops and manufactures surgical devices | Direktor/Vorstandsmitglied | - |
NeoSync, Inc.
 NeoSync, Inc. Medical SpecialtiesHealth Technology Develops medical equipment for central nervous system | Vorsitzender | - |
Ehemalige bekannte Positionen von Lawrence C. Best
| Unternehmen | Position | Ende |
|---|---|---|
| MYRIAD GENETICS, INC. | Direktor/Vorstandsmitglied | 04.12.2020 |
| HAEMONETICS CORPORATION | Direktor/Vorstandsmitglied | 31.07.2014 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Direktor/Vorstandsmitglied | 31.12.2008 |
| BOSTON SCIENTIFIC CORPORATION | Finanzdirektor/CFO | 01.01.2007 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01.01.1992 |
Ausbildung von Lawrence C. Best
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Haemonetics Corp.
 Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems | Health Technology |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Provides molecular biology research to develop new drugs | Commercial Services |
NeoSync, Inc.
NeoSync, Inc. Medical SpecialtiesHealth Technology Develops medical equipment for central nervous system | Health Technology |
4Tech Cardio Ireland Ltd.
4Tech Cardio Ireland Ltd. Medical SpecialtiesHealth Technology Develops and manufactures surgical devices | Health Technology |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Kent State University (Ohio)
 Kent State University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Valtech Cardio Ltd.
 Valtech Cardio Ltd. Medical SpecialtiesHealth Technology Develops devices for mitral valve repair and replacement | Health Technology |
OXO Capital LLC
OXO Capital LLC Financial ConglomeratesFinance Operates as an investment company | Finance |
Cardiovalve Ltd.
 Cardiovalve Ltd. Medical SpecialtiesHealth Technology Develops trans femoral mitral valve replacement system | Health Technology |
